Fingerprint
Dive into the research topics of 'Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
L. Pusztai, C. Denkert, J. O'Shaughnessy, J. Cortes, R. Dent, H. McArthur, S. Kümmel, J. Bergh, Y. H. Park, R. Hui, N. Harbeck, M. Takahashi, M. Untch, P. A. Fasching, F. Cardoso, Y. Zhu, W. Pan, K. Tryfonidis, P. Schmid
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations